Abstract
P0 constitutes 50–60% of protein in peripheral nerve myelin and is essential for its structure and stability. Mutations within the P0 gene (MPZ) underlie a variety of hereditary neuropathies. MpzS63C transgenic mice encode a P0 with a serine to cysteine substitution at position 34 in the extracellular domain of mature P0 (P0S34C), associated with the hypomyelinating Déjérine-Sottas syndrome in human. S63C mice develop a dysmyelinating neuropathy, with packing defects in peripheral myelin. Here, we used x-ray diffraction to examine time-dependent packing defects in unfixed myelin. At ∼7 h post-dissection, WT and S63C(+/+) myelin showed native periods (175 Å) with the latter developing at most a few percent swollen myelin, whereas up to ∼50% of S63C(+/−) (mutant P0 on heterozygous P0 null background) or P0(+/−) myelin swelled to periods of ∼205 Å. In the same time frame, S63C(−/−) myelin was stable, remaining swollen at ∼210 Å. Surprisingly, treatment of whole S63C(−/−) nerves with a reducing agent completely reverted swollen arrays to native spacing and also normalized the swollen arrays that had formed in S63C(+/−) myelin, the genotype most closely related to the human disorder. Western blot revealed P0-positive bands at ∼27 and ∼50 kDa, and MALDI-TOF mass spectrometry showed these bands consisted of Ser34-containing peptides or P0 dimers having oxidized Cys34 residues. We propose that P0S34C forms ectopic disulfide bonds in trans between apposed Cys34 side chains that retard wrapping during myelin formation causing hypomyelination. Moreover, the new bonds create a packing defect by stabilizing swollen membrane arrays that leads to demyelination.
Keywords: Disulfide, Mass Spectrometry (MS), Membrane Proteins, Transgenic, X-ray Scattering, Charcot-Marie-Tooth Neuropathy, Tris(2-carboxyethyl)phosphine Hydrochloride (TCEP), Mice, Myelin Membrane Packing, Myelin Protein Zero
Introduction
P0, a single pass transmembrane protein, is the major structural protein of peripheral nerve myelin where it includes ∼50% of the total protein (1). It has a characteristic immunoglobulin-like extracellular domain that is thought to underlie inter-membrane adhesion via homophilic interactions (2, 3). That P0 is the major structural adhesion molecule in PNS4 myelin for membrane packing at both the cytoplasmic and extracellular appositions is based on structural analysis of myelin in the shiverer mouse, which lacks the myelin basic protein (MBP) in both CNS and PNS but yet has normal myelin arrays in the latter (4). Also consistent with this notion is the finding that P0 knock-out mice lack compaction of myelin (5). Observations on myelin in the shiverer/P0 double null mutant further support the role of P0 at the cytoplasmic apposition (6). One of the molecular contacts in crystals formed by the extracellular domain of P0 under physiological conditions is a 2-fold dimeric interaction between antiparallel molecules that is proposed to be at the adhesion interface between the apposed extracellular surfaces of myelin and to stabilize the native period and membrane packing (2).
Myelin protein zero (MPZ) mutations within the extracellular domain of P0 account for diverse peripheral neuropathies, including Charcot-Marie-Tooth, congenital hypomyelination, and early onset Déjérine-Sottas syndrome (DSS) (1, 7–9). Wrabetz et al. (10) produced and characterized a mouse model of DSS (7) in which a Ser → Cys substitution (P0S34C)5 was introduced into the extracellular domain of P0. This mutation was proposed to produce disulfide aggregates (2, 11, 12) and a toxic gain of function in myelin (13). The mice develop neuromuscular dysfunction by 4–8 weeks of age, and their peripheral nerves show hypomyelination from early postnatal development and subsequent onion bulb formation, which may result from myelin degradation and failed attempts to remyelinate. Interestingly, nerves from the S63C transgenic mouse with varying amounts of endogenous P0wt (S63C(+/+) and S63C(+/−)) show by electron microscopy irregular areas of myelin swelling in a small subset of nerves. The disrupted areas correspond to the intraperiod line (where the extracellular domain is localized); therefore, the amino acid substitution may underlie the evident perturbation of the regular compaction of the membranes (10). By comparison, when P0S34C is expressed on a P0 null background (S63C(−/−)), electron microscopy reveals uniform areas of myelin swelling apparently due to widening of the extracellular apposition by 21% (10).
To explore in detail the inferred instability of myelin in S63C transgenic mouse lines, we analyzed myelin structure in whole, unfixed sciatic nerves using x-ray diffraction (XRD). This technique provides a sensitive and quantitative assessment of internodal myelin structure, membrane packing, and interactions in both a native environment or after physical/chemical treatment (14). As the measurements are carried out on a large volume of nerve rather than just thin sections, there is abundant sampling of internodal myelin (15). In preliminary experiments, we found that the myelin period in nerves from S63C(+/−) resembles that of the native state (175 Å), but after ∼7 h a significant amount of myelin swells to 205-Å period arrays (10). Furthermore, myelin from S63C(−/−) shows an ∼210-Å period, which is significantly larger than the ∼190-Å period for P0(−/−). These initial results suggest that the myelin packing depends on the amount of P0wt and that above a certain ratio of mutant versus WT protein, the former causes instability or dominates the dimeric adhesion interface because of aberrant interactions. Our objective here was to explore further the varied phenotypes of the P0S34C mutation by using XRD to quantitate the packing defects in freshly dissected nerves and in nerves subjected to electrostatic stress (different pH and ionic strength). We found the following: 1) the instability of P0(+/−) myelin derives from the lower level of P0wt, which provides fewer homophilic contacts at the dimeric adhesion interface; 2) the instability of S63C(+/−) myelin derives from the presence of mutant protein, as the total amount of P0 mRNA is nearly twice the wild type level; 3) the presence of the mutant protein renders the myelin more sensitive to pH changes, because of altered interactions involving His52 and Arg45′ near the dimeric adhesion interface; 4) in the absence of any P0wt, formation of a new disulfide between Cys34 and Cys34′ stabilizes swollen myelin arrays; and 5) swollen myelin containing the mutant protein can be “cured” by subjecting the nerve to a reducing agent.
EXPERIMENTAL PROCEDURES
Transgenic Mice
The mice used to analyze myelin structure were bred and maintained on the FVB/N inbred strain at the San Raffaele Scientific Institute (Milano, Italy) and included the following: wild type (WT; P0(+/+)), P0 heterozygous (P0(+/−)), P0null (P0null or P0(−/−)), and S63C on the WT, heterozygous, and null backgrounds (S63C(+/+), S63C(+/−), and S63C(−/−)). The S63C mice have a serine to cysteine substitution at position 34 in the extracellular domain of the processed protein (10). These mice correspond to the line Tg130.3, Tg(MpzS63C)33Mes. Tg130.3 and heterozygous-null mice were crossed to generate the P0S34C mutation on backgrounds with different expression levels of P0wt, resulting in S63C(+/+) (2.2-fold overexpression of P0wt and P0S34C mRNA), S63C(+/−) (1.7-fold overexpression of total P0 mRNA both P0wt and P0S34C mRNAs), and S63C(−/−) (1.2-fold overexpression of P0S34C mRNA).
X-ray Diffraction
Sample Preparation
Sciatic nerves were dissected from wild type and transgenic mice that had been sacrificed by cervical dislocation and decapitation. During dissection, the tissue was continually rinsed with physiological saline (154 mm NaCl, 5 mm Tris base, pH 7.4). After being tied off at each end with fine suture, the nerves were pulled into 0.7–0.9-mm capillary tubes (Charles Supper Co., South Natick, MA) containing the appropriate solution, and the tubes were sealed at both ends with wax. For electrostatic stressing (16), the sciatic nerves were stretched slightly onto a frame (a notched, plastic pipette tip) and placed into scintillation vials containing 20-ml aliquots of solutions of known ionic strength and pH (see below), gently agitated overnight, and then loaded into quartz capillary tubes as described above.
Solutions used were as follows: normal physiological saline, either 154 mm NaCl, 5 mm Trizma® base (tris[hydroxymethyl]aminomethane) titrated with HCl to pH 7.4, or 154 mm NaCl, 5 mm phosphate buffer, adjusted to each desired pH 6–8; hypotonic alkaline saline, 60 mm NaCl and 30 mm NaCl, 5 mm Trizma® base titrated with NaOH to pH 8, and 30 mm NaCl, 5 mm glycine titrated with NaOH to pH 9; hypotonic acidic saline, 60 mm NaCl, 5 mm glycine titrated with HCl to pH 3.1 or 2.1, and 30 mm NaCl, 5 mm glycine buffer titrated with HCl to pH 2.1; alkaline saline, 154 mm NaCl, 5 mm glycine buffer titrated with NaOH to pH 10–10.5. The reducing solution consisted of 10 or 50 mm Tris(2-carboxyethyl)phosphine hydrochloride (TCEP; catalog no. 20490, Pierce) (17, 18), 154 mm NaCl, and 5 mm Trizma® base, titrated with NaOH to pH 7.4.
For preliminary screening of myelin structure, we examined nerves fixed by immersion in 2% glutaraldehyde in 0.12 m phosphate buffer at pH 7.4, maintained in the same fixative during shipment from the San Raffaele Institute (Milano, Italy) to Boston College, and kept in fixative during x-ray diffraction. These findings, which revealed hypomyelination, specifically a one-third decrease in the relative amount of myelin for S63C(+/+) versus WT (supplemental Fig. 1), encouraged us to proceed with analysis of unfixed myelin from whole nerves, as described here.
Perfusion Chamber
To better preserve physiological conditions for nerve, we used a perfusion chamber that allowed continuous flow of solution over the nerve during 20 h of intermittent x-ray data collection. A peristaltic pump (Masterflex, Cole-Parmer, Vernon Hills, IL) maintained the flow from a 300-ml reservoir.
X-ray Diffraction and Myelin Structure Analysis
The experimental details have been described in recent publications (10, 15, 19, 20). Briefly, x-ray diffraction patterns from whole sciatic nerves, freshly dissected from the mice or after overnight treatment under defined conditions, were recorded using an electronic detector. The myelin period (d) was directly measured from the positions of the intensity maxima. After background subtraction, the area of the peaks (or integrated intensities) were used to calculate structure amplitudes that were used to calculate the membrane profiles via Fourier synthesis. From the profiles we measured the inter-membrane spaces at the cytoplasmic and extracellular appositions, and the thickness of the lipid bilayer. Such a calculation was undertaken for diffraction data to ∼30 Å spacing (14). Whereas for native sciatic nerve myelin, a sufficient number of reflections were present, for swollen myelin this occurred only when the swollen phase was the predominant one and had multiple Bragg orders, e.g. S63C(−/−) and P0(−/−). The relative amount of internodal myelin was expressed as M/(M+B), where M is the total integrated intensity of the myelin reflections after background (B) subtraction, and M+B is the total intensity. A scatterplot of M/(M+B) versus myelin period was used to compare the different genotypes (supplemental Figs. 1 and 2). The irregularity (or distortion) in membrane packing (denoted by lattice parameter Δ) was determined by analyzing the peak widths of reflections (15, 21, 22) and was expressed here as a fraction of the periodicity d, or Δ/d. The significance of the difference between the means for different parameters was evaluated using the Student's t test, with p < 0.05 considered significant.
Western Blotting
Myelin was isolated from sciatic nerves of adult mice, as described previously (Ref. 23 with modifications), separated by SDS-PAGE (Fig. 5, A and B) using a pre-cast 4–20% Tris-glycine gradient gel (1.0 mm, 12 wells; Invitrogen), and analyzed by Western blot as described (Fig. 5C and supplemental Fig. 3) (10). For SDS-PAGE, the sample buffer, pH 6.8, contained 2% SDS, 63 mm Tris base, 10% glycerol, and 0.01% bromphenol blue. Isolated myelin samples were loaded and run in an XCELL SurelockTM mini-cell (Invitrogen) for 1–2 h at a constant 125 V. For Western blotting, proteins were electrophoretically transferred onto an Immobilon-P PVDF transfer membrane (Bio-Rad) using an XCell IITM blot module (Invitrogen). Proteins were detected using the ECLTM Western blotting detection reagents and analysis system (GE Healthcare). The membrane was incubated for 1 h with either a 1:2000 dilution of a rabbit polyclonal anti-P0 primary antibody (kindly provided by Dr. David Colman via Dr. Brian Popko), a 1:2000 dilution of a mouse monoclonal anti-P0 primary antibody (P07, kindly provided by Dr. Juan Archelos), or a 1:1000 dilution of polyclonal anti-MBP primary antibody (Santa Cruz Biomedical, Santa Cruz, CA). Proteins were visualized by chemiluminescence according to the manufacturer's instructions, using a peroxidase-labeled anti-rabbit or anti-mouse secondary antibody at 1:10,000 dilution and ECLTM detection reagents. Molecular mass markers were MagicMark (Invitrogen).
Protein Identification by Matrix-assisted Laser Desorption/Ionization-Time of Flight-Mass Spectrometry (MALDI-TOF MS) Analysis
Myelin was isolated from mouse sciatic nerves (as described above) with the addition of 10 mm N-ethylmaleimide (NEM) to the reagents, so all the cysteines present as free thiols in myelin would be NEM-alkylated (supplemental Fig. 4). After SDS-PAGE, the bands of interest were excised from the gel, subjected to reduction by 10 mm DTT and alkylation by 55 mm iodoacetamide (IAA), and finally digested with trypsin overnight (Roche Applied Science) (24). 1-μl aliquots of the supernatant were used for MS analysis on a MALDI-TOF Voyager-DE STR (Applied Biosystems) mass spectrometer using the dried droplet technique and α-cyano-4-hydroxycinnamic acid as matrix. In parallel, bands already treated with trypsin were further digested with Asp-N enzyme overnight (Roche Applied Science); the supernatants were used for MALDI-TOF MS analysis. Peak list was obtained by peak de-isotoping. Spectra were accumulated over a mass range of 750–4000 Da with a mean resolution of about 15,000. Spectra were internally calibrated using matrix signals and trypsin autolysis peaks and then processed via Data Explorer software version 4.0.0.0 (Applied Biosystems). Searches were performed with trypsin and Asp-N specificity; cysteine alkylation by IAA, NEM, and oxidation of methionine were considered as variable modifications. Two missed cleavages per peptide were allowed, and an initial mass tolerance of 50 ppm was used in all searches. Peptides with masses corresponding to those of enzymes and matrix were excluded from the peak list. Proteins were identified by searching a comprehensive nonredundant protein data base (NCBInr 20080912 (7031513 sequences; 2427977331 residues) Taxonomy:Rodentia (222606 sequences)) using Mascot (Matrix Science; version 2.1.04) program.
RESULTS
Chemical stabilization of myelin by aldehyde fixation results in changes in periodicity and membrane packing (25); however, such tissue is useful for an initial screening of myelinated nerves that may have altered amounts of internodal myelin (15). Preliminary screening of glutaraldehyde-fixed sciatic nerves from S63C(+/+) mice revealed consistently weaker myelin diffraction patterns compared with WT nerves. Quantitation showed that there was about one-third less internodal myelin in the transgenic nerves but that the myelin periodicities were not significantly different between the genotypes (supplemental Fig. 1). A preliminary XRD study of the unfixed nerves from S63C mice and electron microscopy of embedded tissue substantiated the hypomyelination (10) and provided the rationale for the current, more systematic study of myelin structural integrity in the S63C genotype series.
Myelin-containing Mutant P0S34C Swelled in Sealed Capillary
Diffraction patterns were recorded from the freshly dissected sciatic nerves of mice with genotypes WT, S63C(+/+), S63C(+/−), S63C(−/−), and P0(+/−). Recorded within 30 min of dissection, the initial 10-min patterns of the nerves, which had been sealed into capillaries containing excess physiological saline, revealed obvious differences in the relative intensities of the patterns and in myelin periods (Fig. 1A; Table 1). From strongest to weakest, the patterns ranked as follows: WT > P0(+/−) > S63C(+/+) ≈ S63C(+/−) > S63C(−/−) > P0(−/−) (null not shown; see Ref. 15). Native periods (∼175 Å) were observed for WT and for S63C on the WT and heterozygous backgrounds, and larger periods were recorded for P0(+/−) (∼5 Å greater than native), P0(−/−) (∼10 Å greater), and S63C on the null background (>30 Å greater). Close inspection of the pattern from S63C(+/−) showed elevated intensity between the 2nd and 3rd Bragg reflections (Fig. 1A, asterisk), which corresponded in position to the predominant intensity maximum from the swollen myelin of S63C(−/−) (Fig. 1, peak labeled 3′). To check for stability of the myelin period and membrane packing, we recorded a subsequent pattern from each nerve about 7 h after the initial pattern (Fig. 1B). Four of the nerves gave patterns virtually identical to the originals as follows: the WT (175 Å) and S63C on the WT background, P0(−/−) (187 Å), and S63C on the null background (207 Å). By contrast, P0(+/−) and S63C(+/−) both showed complex patterns indicating new ∼200-Å period swollen arrays coexisting with native arrays. Measurement of the intensities indicated that there were approximately equal amounts of each type of array. Although its predominant structure was native, the myelin with S63C(+/+) showed an increase in background intensity between the 2nd and 3rd Bragg reflections (*, Fig. 1B) indicating a small amount of swollen myelin. Calculation of membrane profiles (data not shown) from the diffraction data revealed that the larger period was accounted for by ∼30 Å swelling at the extracellular apposition in S63C(−/−) and ∼10 Å swelling in P0(−/−) (Table 1).
TABLE 1.
Timea | Dimensionsb |
Δ/dc | Myelind | M/(M+B)e | |||
---|---|---|---|---|---|---|---|
d | cyt | lpg | ext | ||||
Å | % | ||||||
WT | |||||||
10 min | 175.0 | 31 | 48 | 48 | 0.023 | 0.35 | |
7 h | 174.8 | 31 | 49 | 46 | 0.017 | 0.35 | |
S63C(+/+) | |||||||
10 min | 174.3 | 31 | 47 | 49 | 0.029 | 0.17 | |
7 h | 173.1 | 32 | 46 | 49 | 0.029 | 95 | 0.15 |
∼219 | − | − | − | 5 | |||
S63C(+/−) | |||||||
10 min | 174.9 | 31 | 48 | 49 | 0.029 | 92 | 0.21 |
∼210 | − | − | − | 8 | |||
7 h | 173.2 | − | − | − | 0.023 | 59 | 0.21 |
204.7 | − | − | − | 41 | |||
S63C(−/−) | |||||||
10 min | 210.7 | 33 | 49 | 80 | 0.057 | 0.13 | |
7 h | 207.0 | 31 | 50 | 76 | 0.048 | 0.11 | |
P0(+/−) | |||||||
10 min | 180.1 | 30 | 50 | 50 | 0.028 | 0.28 | |
7 h | 180.2 | 31 | 49 | 51 | 0.022 | 45 | 0.36 |
197.7 | − | − | − | 55 | |||
P0(−/−) | |||||||
10 min | 187.3 | − | − | − | 0.048 | 0.06 | |
7 h | 187.0 | 33 | 46 | 62 | 0.043 | 0.04 |
a Myelin structure was assessed by XRD immediately after dissection and 7 h later.
b The abbreviations used are as follows: d, myelin period, as measured from the diffraction spectra; cyt, cytoplasmic apposition; lpg, separation between lipid polar head group layers; ext, extracellular apposition; all as determined from the membrane density profiles (see “Experimental Procedures” for details).
c The irregularity in the packing of myelin membranes was determined from the breadths of the x-ray reflections (15) and expressed as a fraction of the periodicity d.
d The percentage of the total myelin that is in the swollen state, calculated from Pi = Σh (hIi(h)/di2) (50), where I(h) is the integrated intensity of the peak corresponding to the hth Bragg order, and d is periodicity.
e Relative amount of compact myelin M/(M+B) (see “Experimental Procedures”).
S63C(+/−) and P0(+/−) Also Swelled under More Physiological Conditions
As rat spinal roots (PNS) incubated in a sealed capillary tube undergo swelling over time, probably due to anoxic conditions within the microenvironment (26), we determined whether anoxia was a factor in the swelling of the mutant nerve myelin. Nerves were bathed continuously for ∼20 h from a large reservoir of physiological saline that was exposed to the air, and x-ray patterns were periodically recorded. Myelin in WT and S63C(+/+) nerves was stable throughout the 20 h and exhibited the same native periodicity (Fig. 2, A and B; Table 2). S63C(+/−) initially had a native period (Fig. 2C), but by 5 h, the sciatic nerve had developed an increase in background scatter between the 2nd and 3rd Bragg order reflections (Fig. 2C, *; Table 2), which by 20 h corresponded to be the 3rd order of an ∼221-Å period array. Quantitation of the diffracted intensity indicated that this swollen array accounted for about one-tenth of the ordered myelin. P0(+/−) exhibited a consistent 180-Å period for ∼5 h of perfusion (Fig. 3E), and by 20 h had developed distinct 205-Å period swollen arrays (Bragg orders denoted by 2′, 3′, and 5′). The swollen arrays accounted for one-fifth of the total intensity of the ordered myelin (Table 2). Both S63C(−/−) and P0(−/−) maintained stable swollen arrays during the perfusion, with the periodicity for the myelin containing the mutant protein remaining about 15 Å greater than that for the null mutant (Fig. 2, D and F; Table 2).
TABLE 2.
Time | Dimensions |
Δ/d | Myelin | M/(M+B) | |||
---|---|---|---|---|---|---|---|
d | cyt | lpg | ext | ||||
Å | % | ||||||
WT | |||||||
10 min | 174.7 | 31 | 48 | 47 | 0.023 | 0.38 | |
5 h | 174.7 | 31 | 48 | 47 | 0.023 | 0.42 | |
20 h | 174.7 | 31 | 48 | 47 | 0.023 | 0.41 | |
S63C(+/+) | |||||||
10 min | 175.3 | 31 | 49 | 46 | 0.023 | 0.30 | |
5 h | 175.1 | 31 | 49 | 46 | 0.023 | 0.31 | |
20 h | 174.4 | 30 | 49 | 46 | 0.023 | 0.29 | |
S63C(+/−) | |||||||
10 min | 175.9 | 33 | 47 | 49 | 0.028 | 0.23 | |
5 h | 175.9 | 33 | 47 | 49 | 0.023 | 95 | 0.27 |
196.5 | 5 | ||||||
20 h | 174.7 | 31 | 47 | 49 | 0.029 | 88 | 0.25 |
220.5 | 12 | ||||||
S63C(−/−) | |||||||
10 min | 206.0 | 0.049 | 0.14 | ||||
5 h | 208.4 | 0.048 | 0.15 | ||||
20 h | 205.4 | 0.054 | 0.21 | ||||
P0(+/−) | |||||||
10 min | 179.5 | 33 | 48 | 50 | 0.028 | 0.29 | |
5 h | 180.6 | 33 | 50 | 48 | 0.028 | 0.27 | |
20 h | 181.9 | 34 | 49 | 50 | 0.033 | 79 | 0.21 |
204.6 | 21 | ||||||
P0(−/−)a | |||||||
20 min | 191.2 | 0.037 | 0.10 | ||||
5 h | 191.7 | 0.042 | 0.09 |
a P0(−/−) sciatic nerve was too weak to withstand lengthy perfusion, so only data at 5 h are shown.
pH-induced Swelling for S63C(+/−) and P0(+/−) Myelin Differed from WT
Inter-membrane stability at the extracellular apposition of myelin is thought to depend on the homophilic interactions between apposed P0 molecules, which involves the His52 and Arg45′ residues at the 2-fold dimeric adhesion interface (2). As this polar interaction is likely to be labile to changes in pH (16) and also to be affected by the substitution of the proximal residue Ser34 by Cys, we investigated whether the panel of S63C genotypes was differentially affected by changes in pH.
Sciatic nerves were treated with solutions ranging from pH 6 to 8 (Fig. 3, A and B; supplemental Table 1). Previously, it had been shown for WT mouse sciatic myelin that decreasing the pH to 6.5–7.0 causes swelling (16). The resulting threshold for such swelling was at a higher pH ∼7.5 for both S63C(+/−) and P0(+/−) as follows: S63C(+/−) had two phases (174 and 232 Å), the latter accounting for a few percent of ordered myelin; and P0(+/−) had two phases (180 Å and 217 Å), where the swollen arrays constituted 13% of the myelin (supplemental Table 1). Compaction to the native period for these nerves occurred in the range pH 7.6–8, indicating that they are more stable at alkaline pH. The threshold for S63C(+/+) was closer to that of WT, as at pH 7.0 only a small amount of swelling (∼3%) was evident. By contrast with these genotypes, S63C(−/−) myelin throughout the entire pH range displayed a swollen period of ∼209 ± 4 Å, suggesting that some specific interaction may underlie stability of the swollen period. The period for P0(−/−) in the same pH range was 191 ± 7 Å. Thus, the presence of the mutant P0 in the absence of P0wt resulted in a stable membrane separation that in swollen myelin was nearly 20 Å greater than without the protein. Moreover, in the linear regressions for these data, the standard error for the periodicity in S63C(−/−) myelin was nearly one-third that for the P0(−/−) myelin, suggesting an intermembrane stabilizing interaction in the former.
Comparison of Membrane Packing Regularity among the Genotypes
To analyze the disorder in the stacking of the myelin membranes, we plotted the integral widths of the x-ray reflections w2 versus the Bragg order h4 for the different sets of diffraction data from the six genotypes examined in this study (see “Experimental Procedures”) (15). The membrane packing disorder (Δ/d) in S63C(−/−) was nearly double that in the wild type and heterozygous (S63C(+/−)) myelins; and the mutation resulted in less regular packing of lamellae than membranes totally lacking P0 (Table 1). Overall, when ranked from greatest to least packing regularity (expressed as Δ/d), the genotypes were as follows: WT > S63C(+/+) ≈ S63C(+/−) ≈ P0(+/−) > P0(−/−) > S63C(−/−). (The significance levels for this comparison ranged from p < 0.0001–0.04.)
Reducing Agent Reverted Swollen Myelin of S63C(+/−) to Native Spacing
That the extracellular domains of P0 interact homophilically and the substituted residue is located toward the apex of this domain raised the possibility that formation of a new disulfide between Cys34 and Cys34′ (2, 11, 13) could account for the stability of the swollen membranes in S63C(−/−). To test this idea, we used TCEP as a reducing agent in which to incubate the S63C nerves. TCEP is a thiol-free reducing agent that is proposed to be more effective than either dithiothreitol (DTT) or mercaptoethanol, and it has the advantages of stoichiometric reduction (1 mol of TCEP reduces 1 mol of protein disulfide), no detection in modifications of other residues other than cysteine, and being nonvolatile, water-soluble, and odorless (17).
Experiments in parallel were undertaken with WT nerves to control for the possibility that TCEP might also reduce the disulfide that stabilizes the β-sheets within the extracellular domain (2). Membrane packing effects were assessed by analysis of the diffraction patterns after 15–20 h of incubation of nerves in 0, 10, and 50 mm TCEP (added to physiological saline at pH 7.4). WT myelin retained a native or near-native period (Fig. 4A; Table 3), whereas the swollen myelin of both S63C(+/−) and S63C(−/−) reverted to the native period with TCEP treatment (Fig. 4, B and C; Table 3). At 10 mm TCEP, both swollen and native period arrays were detected in the S63C(−/−) nerve. The membrane profiles calculated from the diffraction data showed an ∼36-Å decrease in width of the extracellular apposition (Table 3). When S63C(−/−) compacted to the native period, the myelin became more regularly packed (Table 3; Δ/d).
TABLE 3.
TCEP | Dimension |
Δ/d | Myelin | M/(M+B) | |||
---|---|---|---|---|---|---|---|
d | cyt | lpg | ext | ||||
mm | Å | % | |||||
WT | |||||||
0 | 175.0 | 31 | 49 | 46 | 0.017 | 0.30 | |
10 | 175.0 | 31 | 49 | 46 | 0.023 | 0.34 | |
50 | 177.0 | 34 | 49 | 45 | 0.023 | 0.38 | |
S63C(+/−) | |||||||
0 | 176.0 | 33 | 47 | 49 | 0.023 | 80 | 0.30 |
218.7 | 20 | ||||||
10 | 177.0 | 33 | 49 | 46 | 0.023 | 0.27 | |
50 | 176.0 | 33 | 48 | 47 | 0.023 | 0.27 | |
S63C(−/−) | |||||||
0 | 211.0 | 33 | 46 | 86 | 0.033 | 0.19 | |
10 | 187.3 | 26 | 0.16 | ||||
222.3 | 74 | ||||||
50 | 180.0 | 32 | 49 | 50 | 0.028 | 0.12 |
Western Blotting and MALDI-TOF MS Confirmed Novel Disulfide Formation
To demonstrate chemically whether P0S34C forms intermolecular disulfide bonds in myelin, we performed SDS-PAGE on purified myelin from WT, S63C(+/+), S63C(+/−), and S63C(−/−) adult nerves, under reducing or nonreducing conditions (Fig. 5). Using either a rabbit polyclonal (Fig. 5A) or a mouse monoclonal (Fig. 5C) anti-P0 antibody, we could clearly detect in all samples under nonreducing conditions a band of relative mobility of ∼27 kDa (the expected size of WT P0, *) and in the S63C(−/−), S63C(+/−), S63C(+/+) samples, a band at ∼50 kDa (arrowhead) that disappeared after treatment with reducing agents. Neither of these bands was detected in sciatic nerve extracts from P0(−/−) mice after blotting with the same antibodies (supplemental Fig. 1 and data not shown), indicating that these two bands represented P0.
To characterize the proteins present in the 27- and 50-kDa bands, myelin was purified with NEM-containing reagents to alkylate all cysteines present as free thiols and then subjected to SDS-PAGE. The bands of interest were then excised from the gel (Fig. 5C) and subjected to MALDI-TOF MS. The ∼27-kDa band consisted of peptides containing either Ser34 or Cys34, whereas the ∼50-kDa band consisted only of peptides containing Cys34 (supplemental Fig. 4 with supplemental datasets). Importantly, in the 50-kDa band, the peptides containing Cys34 were all found modified with IAA, indicating that the Cys had been in the oxidized form in myelin and that it had been reduced only after extraction from the gel (Fig. 5D and supplemental Fig. 4). By contrast, peptides containing Cys34 in the 27-kDa band were found modified with both NEM (meaning that they were as free thiol in the cell lysate) and IAA (Fig. 5D and supplemental Fig. 4). This analysis provides further evidence supporting the hypothesis that Cys34 is involved in abnormally positioned disulfide bond formation in myelin.
DISCUSSION
Initial Screening of Sciatic Nerve Myelin from S63C Mice
Aldehyde fixation of WT nerves introduces small alterations in myelin packing (25), which are mostly in periodicity and membrane structure rather than in relative amount of myelin (15). For this study, an initial assessment of fixed sciatic nerve by XRD showed that the S63C(+/+) had about one-third less internodal (compact) myelin than WT (supplemental Fig. 1). Subsequently, XRD results from a limited sample of unfixed S63C nerves suggested reduced amounts of myelin, altered periodicity, and instability; and EM analysis of S63C(+/+) myelin revealed irregular areas of expansion in small subsets of the myelin lamella (10). As a result of these findings, we conducted a systematic study of freshly dissected nerves from the various genotypes of S63C transgenic mice to determine in unfixed nerves (native conditions) the amount and localization of packing disorder and myelin instability.
Instability of S63C Myelin
Initial diffraction patterns of S63C(+/−) revealed that there are two myelin periods at physiological pH (pH 7.4), 175 and ∼210 Å (Fig. 1; Table 2). S63C(+/+) and P0(+/−) myelin swelled after 7 h in the sealed capillary tube, whereas S63C(−/−) maintained a stable ∼210-Å period. The relative amount of myelin for S63C(+/+), S63C(+/−), and S63C(−/−) was reduced by about one-half, consistent with the idea that the S34C mutation causes hypomyelination along with demyelination, as indicated by EM (10). When the S63C(+/−) sciatic nerves were examined after 7 h in a sealed capillary tube, the percentage of swollen myelin increased, suggesting myelin instability. Previous studies have shown that treatment of PNS nerves under anoxic conditions, e.g. in an oxygen-deprived environment such as a sealed capillary, may cause myelin swelling (26). Metabolism of cellular glucose without oxygen might decrease the pH, causing the myelin to swell (16). To test whether anoxia caused the swelling, nerves were placed in a perfusion chamber that allowed for the continuous flow of aerated physiological saline over the nerve during recording of the XRD patterns (Fig. 2; Table 2).
Diffraction from perfused S63C sciatic nerve demonstrated that over a duration of 20 h the S63C(+/−) myelin still swelled (to ∼210 Å), and the swelling started as early as 5 h and progressed to account for about 12% of the myelin (Table 2). This result suggests that the instability of myelin in the transgenic sciatic nerves was due to the mutation itself and not to anoxia. P0(+/−) sciatic nerve also showed instability, as it developed a swollen phase after 20 h of perfusion. The instability of P0(+/−) is most likely due to fewer homophilic contacts because of the lowered amount of WT P0. Perfusion of S63C(−/−) for 20 h revealed that the swollen myelin membranes were stable, even though the myelin was less ordered (Fig. 2D; Table 2).
S63C(+/−) Nerve Displayed Myelin Stability at More Alkaline pH
The effects of pH and ionic strength on membrane-membrane interactions in myelin have been determined by XRD measurements on nerves from normal (16) and transgenic (10, 15, 20, 27) mice. These studies demonstrate that at physiological ionic strength WT nerves transition from a compact phase (∼165 Å) at pH 4–5 to a swollen phase (∼220 Å) at pH 5–7 and to a native phase (∼176 Å) at pH 7–10. Here, we treated nerves at different pH values to detect membrane packing alterations arising from the Cys34 mutation. S63C(+/−) did not transition to a native phase until at pH >7.6, unlike WT that transitioned at pH 6.6 (Fig. 3; supplemental Table 1). This result indicates that myelin membrane interactions in S63C(+/−) at physiological ionic strength depends on pH for stability. By contrast, S63C(−/−) did not switch at all to the native period structure, indicating that the Cys34 mutation somehow contributes to stabilizing the swollen array. The myelin containing only one copy of the Mpzwt (P0(+/−)) also showed a swollen period until more alkaline pH, apparently due to a P0 dosage effect.
Studies on the amino acid substitution Ser →Cys in the P0 extracellular domain show that the mutant P0S34C is incorporated into the sheath, where it produces packing defects (10). The sciatic nerves of S63C mice exhibit onion bulb formation and have thinner sheaths, which are compatible with the DSS phenotype in humans (28). Because of P0 dosage, a valid model of S34C could not be produced with one mutant allele and one WT allele, due to the resultant overexpression of P0. Based on mRNA levels, the S63C(+/−) mice express 170% of normal P0 levels, and thus exhibit the overexpression phenotype of dose-dependent dysmyelination (10, 29). The S63C(−/−) expresses near normal P0 dosage (120% overexpression), but it lacks the MpzWT. The overexpression of P0 results in thinner myelin sheaths, which also could explain the hypomyelination observed in S63C(+/−). However, S63C(−/−) exhibits nearly normal P0 expression levels, indicating that the observed hypomyelination is independent of expression level and is caused by the mutation. The effect of the specific amino acid substitution can be additionally seen in the formation of two coexisting myelin arrays, swollen and native, with the swollen array of ∼210 Å extremely stable in both S63C(+/−) and S63C(−/−). The swollen myelin is corroborated by EM in S63C(+/−) and S63C(−/−) sciatic nerves (10). Moreover, EM analysis of P0 overexpression (30–80% overexpression) reveals that the periodicity is apparently normal in the few thin myelin sheaths present (29). These points offer further validation that the structural changes in the sciatic nerves of S63C mice are due to the effects of the mutation rather than to the overexpression of P0.
S34C Most Likely Disrupted the Homophilic Binding Interface between Mutant and WT P0 Dimers
A dimeric, homophilic adhesion site involving amino acid residues His52 and Arg45′ on the extracellular domains of opposing P0 molecules has been proposed (2). The cysteine (Cys34) that substitutes for serine in the S63C mouse is in proximity to the proposed dimer interface and could destabilize the interaction between the histidine imidazole ring (His52) and arginine guanidine group (Arg45′) (2, 3) by formation of a cis-cysteine-histidine interaction due to pK shifts (Table 4). We propose that perturbation of the local electrostatic interaction could account for the pKa shift. The proton dissociation constant (pKa) of the residues in the crystallographic model of the extracellular domain (rat extracellular domain, Protein Data Bank code 1NEU; Table 4) was determined using PROPKA (30). When the atomic coordinates of the P0wt dimer were used for the calculation, the pKa of His52 was found to be pH 4.24, likely due to the local increase in [OH−] concentration arising from the electrostatic influence of the Arg45′ residue on the opposing P0 molecule. Swiss Viewer was used to construct the atomic structure of the dimeric P0 extracellular domain containing the point mutation S34C from the x-ray crystal structure of rat P0, and it subsequently was energy-minimized to make it stereochemically reasonable. When the pKa values for the Cys34 mutant were estimated by PROPKA (Table 4) (30), the substitution resulted in a pK shift to pH 10.24 for His52 and to pH 0.96 for Cys34 (31–35). This would result in deprotonation of the cysteine thiol by the positively charged histidine, with formation of a cis cysteine-histidine interaction, which would be expected to weaken the His52–Arg45′ interaction, facilitating swelling. Thus, a positive-charged P0 dimer interface can account for swelling in S63C(+/−) myelin.
TABLE 4.
Amino acid | Monomer | WT dimer | S34C(+/+) dimer |
---|---|---|---|
Cys34 | 0.96 | ||
His52 | 6.43 | 4.24 | 10.24 |
Arg45 | 12.50 | 12.08 | 12.08 |
Novel Disulfide Accounted for Swollen Arrays in S63C(+/−) and S63C(−/−) Myelin
As the amino acid substituent is a cysteine residue and the P0 interactions are homophilic, we examined the possibility that formation of a disulfide bond might stabilize the swollen myelin. When S63C(+/−) and S63C(−/−) were treated with TCEP (thiol-free reducing agent), the swollen arrays disappeared (Fig. 4, B and C), whereas WT, under the same conditions, remained unaltered in period (Fig. 4A). The decrease in period was accounted for by a large reduction of the width in the extracellular apposition (Table 3). Modeling this disulfide bond between P0 extracellular domains from the crystal structure revealed that if a Cys34–Cys34′ disulfide forms, then the width of the extracellular apposition should measure ∼70 Å (Fig. 6B), which is close to that observed for S63C(−/−) (Table 3), compared with the ∼47 Å spacing found in the WT (Fig. 6A) (2, 36).
During PNS myelin development, the Schwann cell elaborates its plasma membrane, which initially loosely spirals around a single axon. During further development, the membrane forms a more regular spiral (37). EM thin sections indicate that at the initial stages of myelination, the extracellular apposition is widened with a regular gap at the same time that cytoplasm persists in the cytoplasmic space between membranes (see Figs. 6 and 7 and page 231 in Ref. 37). As myelination proceeds, the extracellular gap narrows, and the residual cytoplasm is lost, forming the major dense line and double intraperiod line at the cytoplasmic and extracellular apposition, respectively. In modeling the extracellular domain of P0, we hypothesized that the apposed molecules would align head-to-head during myelination, and subsequently slip by one another, overlapping to form dimers leading to the compaction and native periodicity of myelin (3). This head-to-head model is consistent with the developmental changes in the extracellular apposition as visualized using EM (described above). As the peripheral myelin compacts during development in the S63C mice, the location of the Cys34 residues on apposing membranes apparently allows formation of a disulfide bond. In the S63C(−/−), all dimeric interactions between the P0 tetrameric assemblies of opposing membranes are dictated by the disulfide bond, giving rise to the stable swollen period of ∼210 Å observed by XRD. The widened period is due to the expansion of the extracellular space by ∼70 Å, from the crystal structure (Fig. 6), and indicated by XRD analysis of unfixed sciatic nerve of S63C mice. In the P0 S63C(+/−) myelin, the disulfide bond apparently forms only in cases where two mutant proteins interact at the 2-fold dimeric interface. This would result in only a small amount of swollen myelin, as confirmed by XRD, which showed that ∼20% of the myelin was swollen.
An overview of the diffraction data for the predominant myelin arrays in unfixed nerves from the genotypes examined here (supplemental Fig. 2) shows that there was no significant difference in periodicity among WT, S63C(+/+), and S63(+/−). These three did, however, differ significantly in period from S63C(−/−), P0(+/−), and P0(−/−). In fact, the consistently smaller period for S63C(+/−) compared with P0(+/−) indicates that the myelin having P0S34C is somewhat more adhesive than myelin with P0wt. At higher concentrations of the substituted protein (P0S34C), the trans disulfide bonds predominate, and the periodicity of S63C(−/−) myelin greatly exceeds that of P0(+/−).
In this study, we provide several strands of evidence in support of these trans disulfide bonds. TCEP is a thiol-free reducing agent that is more effective than both oxidized DTT or mercaptoethanol (17). XRD analysis demonstrated that incubation of sciatic nerves of S63C mice in TCEP/physiological saline at pH 7.4 led to reversion of the swollen arrays to native periodicity (∼180 Å). Moreover, Western blot analysis of myelin revealed an ∼50-kDa band under nonreducing conditions that was also abolished under reducing conditions. This band, identified using two different P0 antibodies, contained P0 as it was not detected in P0 null myelin analyzed in parallel by both Western blot and mass spectrometric analyses. Finally, alkylation followed by reduction and mass spectrometry identified only Cys34-containing peptides in the 50-kDa band, and then only in the oxidized state, although we identified both Ser34 and Cys34 peptides in both the reduced and oxidized state in the 27-kDa band. The sum of these data strongly supports that some P0S34C are bound covalently by trans disulfide bonds, which likely account for the swollen myelin.
The possibility that Cys34 is also covalently bound with the normal endogenous Cys21 or Cys98 cannot be eliminated because we have not directly identified Cys34=Cys34 dimer-containing peptides. However, we identified Cys21 in the oxidized state (and not Cys98) only in the 27-kDa band and not in the 50-kDa. Finally, such Cys34=Cys21 or Cys34=Cys98 dimers would require a significant level of unfolding to expose Cys21 or Cys98. Unfolding of other P0 mutants, such as P0S34del, causes retention of the mutant protein in the endoplasmic reticulum and blocks arrival to myelin (10, 38). Thus, these P0-P0 covalent dimers are unlikely to be found in internodal myelin of S63C mice. (An additional cysteine at position 153 is intracellular and is therefore inaccessible to Cys21 or Cys98 in the extracellular domain of P0.)
Genotype/Phenotype Considerations
We envision two mechanisms by which P0=P0 dimer formation that is trans head-to-head and covalent could cause the mixed hypomyelinating/demyelinating neuropathy documented in S63C nerves (10). First, formation of trans covalent dimers during myelination would likely arrest mesaxonal wrapping, such as has been suggested for premature noncovalent adhesion in developing nerves in P0-overexpressing transgenic mice (29, 39). This provides further evidence for the idea that P0 interactions in trans must be carefully regulated during wrapping.
Second, in mature (albeit thin) myelin, the presence of P0wt in the hemizygous transgenic nerves would introduce heterogeneous homophilic (sometimes covalent) interactions, leading to inconsistent packing and the instability observed by XRD analysis. This local instability could alter the dynamic inter-membrane interactions of myelin, which at a more macroscopic scale could result in damage to some internodes and myelin destruction. This model is supported by the finding of onion bulbs in S63C nerves, suggesting demyelination followed by inefficient remyelination (as in mechanism 1 above).
Altered myelin structure ultimately leads to phenotypic neuropathies, given that myelin packing and nerve conduction are intimately connected. For example, studies in the Trembler mouse mutant, which has a defect in the myelin PMP-22 gene (40, 41), show a reduction of axonal diameter (42), altered slow axonal transport, altered regeneration of the axon (43), decrease in neurofilament (NF) phosphorylation, and an increase in NF density (44). One striking aspect of the changes in NF phosphorylation is the concomitant decrease in axon diameter in areas of the axon where there is demyelination (44). The other segments of the same axon may be unaffected, resulting in the Schwann cell affecting local axonal morphology, in turn altering neuronal function of the entire axon. Axonal diameter increases the speed of action potential conduction, and the changes in NF density and NF phosphorylation effectively alter the electrophysiology of the nerves (44). Alterations such as these have also been documented in diabetic neuropathies (45, 46) and in hereditary neuropathies including Charcot-Marie-Tooth and DSS (47, 48). Also, in a nerve biopsy from a CMT1A patient, a reduction in axonal caliber and evidence of NF dephosphorylation were observed (48). These changes can lead to axonal degeneration, particularly in the distal regions, resulting in irreversible clinical consequences, such as muscle atrophy and sensory dysfunction (49).
Supplementary Material
This work was supported, in whole or in part, by National Institutes of Health Grants NS55256 and NS45630 from NINDS. This work was also supported by institutional funds from Boston College (to D. A. K.), Telethon, Italy, Grants GGP07100 and GGP08021, and European Community Grants NGIDD-HEALTH-F2-2008-201535 (to L. W. and M. L. F.).
The on-line version of this article (available at http://www.jbc.org) contains supplemental Table 1, Figs. 1–4, and datasets.
In this paper we number the residues according to the processed protein. For the preprotein, which includes the signal peptide, the mutation is referred to as S63C.
- PNS
- peripheral nervous system
- MBP
- myelin basic protein
- TCEP
- Tris(2-carboxyethyl)phosphine hydrochloride
- NEM
- N-ethylmaleimide
- DSS
- Déjérine-Sottas syndrome
- IAA
- iodoacetamide
- NF
- neurofilament
- XRD
- x-ray diffraction.
REFERENCES
- 1.Kirschner D. A., Wrabetz L., Feltri M. L. (2004) in Myelin Biology and Disorders (Lazzarini R. A., Griffin J. W., Lassmann H., Nave K. A., Miller R. H., Trapp B. D. eds) pp. 523–545, Elsevier/Academic Press, Amsterdam [Google Scholar]
- 2.Shapiro L., Doyle J. P., Hensley P., Colman D. R., Hendrickson W. A. (1996) Neuron 17, 435–449 [DOI] [PubMed] [Google Scholar]
- 3.Wells C. A., Saavedra R. A., Inouye H., Kirschner D. A. (1993) J. Neurochem. 61, 1987–1995 [DOI] [PubMed] [Google Scholar]
- 4.Kirschner D. A., Ganser A. L. (1980) Nature 283, 207–210 [DOI] [PubMed] [Google Scholar]
- 5.Giese K. P., Martini R., Lemke G., Soriano P., Schachner M. (1992) Cell 71, 565–576 [DOI] [PubMed] [Google Scholar]
- 6.Martini R., Mohajeri M. H., Kasper S., Giese K. P., Schachner M. (1995) J. Neurosci. 15, 4488–4495 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Hayasaka K., Himoro M., Sawaishi Y., Nanao K., Takahashi T., Takada G., Nicholson G. A., Ouvrier R. A., Tachi N. (1993) Nat. Genet. 5, 266–268 [DOI] [PubMed] [Google Scholar]
- 8.Shy M. E., Jáni A., Krajewski K., Grandis M., Lewis R. A., Li J., Shy R. R., Balsamo J., Lilien J., Garbern J. Y., Kamholz J. (2004) Brain 127, 371–384 [DOI] [PubMed] [Google Scholar]
- 9.Shy M. E., Garbern J. Y., Kamholz J. (2002) Lancet Neurol. 1, 110–118 [DOI] [PubMed] [Google Scholar]
- 10.Wrabetz L., D'Antonio M., Pennuto M., Dati G., Tinelli E., Fratta P., Previtali S., Imperiale D., Zielasek J., Toyka K., Avila R. L., Kirschner D. A., Messing A., Feltri M. L., Quattrini A. (2006) J. Neurosci. 26, 2358–2368 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Kirschner D. A., Saavedra R. A. (1994) J. Neurosci. Res. 39, 63–69 [DOI] [PubMed] [Google Scholar]
- 12.Kirschner D. A., Szumowski K., Gabreëls-Festen A. A., Hoogendijk J. E., Bolhuis P. A. (1996) J. Neurosci. Res. 46, 502–508 [DOI] [PubMed] [Google Scholar]
- 13.Warner L. E., Hilz M. J., Appel S. H., Killian J. M., Kolodry E. H., Karpati G., Carpenter S., Watters G. V., Wheeler C., Witt D., Bodell A., Nelis E., Van Broeckhoven C., Lupski J. R. (1996) Neuron 17, 451–460 [DOI] [PubMed] [Google Scholar]
- 14.Kirschner D. A., Blaurock A. E. (1992) in Myelin: Biology and Chemistry (Martenson R. E. ed) pp. 3–78, CRC Press, Inc., Boca Raton, FL [Google Scholar]
- 15.Avila R. L., Inouye H., Baek R. C., Yin X., Trapp B. D., Feltri M. L., Wrabetz L., Kirschner D. A. (2005) J. Neuropathol. Exp. Neurol. 64, 976–990 [DOI] [PubMed] [Google Scholar]
- 16.Inouye H., Kirschner D. A. (1988) Biophys. J. 53, 235–245 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Han J. C., Han G. Y. (1994) Anal. Biochem. 220, 5–10 [DOI] [PubMed] [Google Scholar]
- 18.Levison M. E., Josephson A. S., Kirschenbaum D. M. (1969) Experientia 25, 126–127 [DOI] [PubMed] [Google Scholar]
- 19.Agrawal D., Hawk R., Avila R. L., Inouye H., Kirschner D. A. (2009) J. Struct. Biol. 168, 521–526 [DOI] [PubMed] [Google Scholar]
- 20.Yin X., Baek R. C., Kirschner D. A., Peterson A., Fujii Y., Nave K. A., Macklin W. B., Trapp B. D. (2006) J. Cell Biol. 172, 469–478 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Alexander L. E. (1979) X-ray Diffraction Methods in Polymer Science, Krieger, Huntington, NY [Google Scholar]
- 22.Inouye H., Karthigasan J., Kirschner D. A. (1989) Biophys. J. 56, 129–137 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Norton W. T., Poduslo S. E. (1973) J. Neurochem. 21, 749–757 [DOI] [PubMed] [Google Scholar]
- 24.Shevchenko A., Wilm M., Vorm O., Mann M. (1996) Anal. Chem. 68, 850–858 [DOI] [PubMed] [Google Scholar]
- 25.Kirschner D. A., Hollingshead C. J. (1980) J. Ultrastruct. Res. 73, 211–232 [DOI] [PubMed] [Google Scholar]
- 26.Blaurock A. E., Genter St Clair M. B., Graham D. G. (1991) Neuropathol. Appl. Neurobiol. 17, 309–321 [DOI] [PubMed] [Google Scholar]
- 27.Flores A. I., Narayanan S. P., Morse E. N., Shick H. E., Yin X., Kidd G., Avila R. L., Kirschner D. A., Macklin W. B. (2008) J. Neurosci. 28, 7174–7183 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Ouvrier R. A., McLeod J. G., Conchin T. E. (1987) Brain 110, 121–148 [DOI] [PubMed] [Google Scholar]
- 29.Wrabetz L., Feltri M. L., Quattrini A., Imperiale D., Previtali S., D'Antonio M., Martini R., Yin X., Trapp B. D., Zhou L., Chiu S. Y., Messing A. (2000) J. Cell Biol. 148, 1021–1034 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Li H., Robertson A. D., Jensen J. H. (2005) Proteins 61, 704–721 [DOI] [PubMed] [Google Scholar]
- 31.Jez J. M., Noel J. P. (2000) J. Biol. Chem. 275, 39640–39646 [DOI] [PubMed] [Google Scholar]
- 32.Lewis S. D., Johnson F. A., Shafer J. A. (1976) Biochemistry 15, 5009–5017 [DOI] [PubMed] [Google Scholar]
- 33.Lewis S. D., Johnson F. A., Shafer J. A. (1981) Biochemistry 20, 48–51 [DOI] [PubMed] [Google Scholar]
- 34.Pinitglang S., Watts A. B., Patel M., Reid J. D., Noble M. A., Gul S., Bokth A., Naeem A., Patel H., Thomas E. W., Sreedharan S. K., Verma C., Brocklehurst K. (1997) Biochemistry 36, 9968–9982 [DOI] [PubMed] [Google Scholar]
- 35.Whitaker J. R., Bender M. L. (1965) J. Am. Chem. Soc. 87, 2728–2737 [DOI] [PubMed] [Google Scholar]
- 36.Kirschner D. A., Inouye H., Ganser A. L., Mann V. (1989) J. Neurochem. 53, 1599–1609 [DOI] [PubMed] [Google Scholar]
- 37.Peters A., Palay S. L., Webster H. D. (1991) The Fine Structure of the Nervous System: Neurons and Their Supporting Cells, 3rd Ed., Oxford University Press, New York [Google Scholar]
- 38.Pennuto M., Tinelli E., Malaguti M., Del Carro U., D'Antonio M., Ron D., Quattrini A., Feltri M. L., Wrabetz L. (2008) Neuron 57, 393–405 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Yin X., Kidd G. J., Wrabetz L., Feltri M. L., Messing A., Trapp B. D. (2000) J. Cell Biol. 148, 1009–1020 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.Suter U., Moskow J. J., Welcher A. A., Snipes G. J., Kosaras B., Sidman R. L., Buchberg A. M., Shooter E. M. (1992) Proc. Natl. Acad. Sci. U.S.A. 89, 4382–4386 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41.Suter U., Welcher A. A., Ozcelik T., Snipes G. J., Kosaras B., Francke U., Billings-Gagliardi S., Sidman R. L., Shooter E. M. (1992) Nature 356, 241–244 [DOI] [PubMed] [Google Scholar]
- 42.Aguayo A. J., Attiwell M., Trecarten J., Perkins S., Bray G. M. (1977) Nature 265, 73–75 [DOI] [PubMed] [Google Scholar]
- 43.de Waegh S., Brady S. T. (1990) J. Neurosci. 10, 1855–1865 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44.de Waegh S. M., Lee V. M., Brady S. T. (1992) Cell 68, 451–463 [DOI] [PubMed] [Google Scholar]
- 45.Medori R., Autilio-Gambetti L., Jenich H., Gambetti P. (1988) Neurology 38, 597–601 [DOI] [PubMed] [Google Scholar]
- 46.Medori R., Jenich H., Autilio-Gambetti L., Gambetti P. (1988) J. Neurosci. 8, 1814–1821 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 47.Martini R. (2001) Muscle Nerve 24, 456–466 [DOI] [PubMed] [Google Scholar]
- 48.Watson D. F., Nachtman F. N., Kuncl R. W., Griffin J. W. (1994) Neurology 44, 2383–2387 [DOI] [PubMed] [Google Scholar]
- 49.Bjartmar C., Yin X., Trapp B. D. (1999) J. Neurocytol. 28, 383–395 [DOI] [PubMed] [Google Scholar]
- 50.Kirschner D. A., Caspar D. L. (1975) Proc. Natl. Acad. Sci. U.S.A. 72, 3513–3517 [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.